Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy

Drexel University

Status: Terminated

Conditions: Epilepsy; Vitamin D Deficiency; Magnesium Deficiency

Treatments: Other: No Intervention. Study is Cross Sectional in nature

Study type: Observational

Funder types: Other

Identifiers

NCT03471481

150003722

Details and patient eligibility

About

The objective of this study is to determine the role of magnesium on bone and vitamin D metabolism in patients receiving anti-epileptic medications.

Enrollment: 7 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Individuals receiving anti-epileptic drugs as a treatment for epilepsy

Exclusion criteria

• Individuals who are pregnant or breastfeeding, receiving cancer treatments, have liver or kidney diseases, autoimmune diseases, or other diseases that may interfere with vitamin D and magnesium metabolism.